Tatva Chintan Pharma Chem Limited (IN:TATVA)
:TATVA
Want to see IN:TATVA full AI Analyst Report?
Total Valuation
Tatva Chintan Pharma Chem Limited has a market cap or net worth of ₹26.04B. The enterprise value is ₹27.62B.
Market Cap₹26.04B
Enterprise Value₹27.62B
Share Statistics
Tatva Chintan Pharma Chem Limited has 23,392,056 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding23,392,056
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Tatva Chintan Pharma Chem Limited’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 4.59%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)4.59%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee7.34M
Profits Per Employee610.36K
Employee Count689
Asset Turnover0.50
Inventory Turnover1.65
Valuation Ratios
The current PE Ratio of Tatva Chintan Pharma Chem Limited is 62.0. Tatva Chintan Pharma Chem Limited’s PEG ratio is 0.09.
PE Ratio62.0
PS Ratio4.87
PB Ratio3.15
Price to Fair Value3.15
Price to FCF-29.25
Price to Operating Cash Flow194.79
PEG Ratio0.09
Income Statement
In the last 12 months, Tatva Chintan Pharma Chem Limited had revenue of 5.06B and earned 420.54M in profits. Earnings per share was 17.98.
Revenue5.06B
Gross Profit1.82B
Operating Income563.11M
Pretax Income570.09M
Net Income420.54M
EBITDA931.58M
Earnings Per Share (EPS)17.98
Cash Flow
In the last 12 months, operating cash flow was 133.81M and capital expenditures -559.99M, giving a free cash flow of -426.18M billion.
Operating Cash Flow133.81M
Free Cash Flow-426.18M
Free Cash Flow per Share-18.22
Dividends & Yields
Tatva Chintan Pharma Chem Limited pays an annual dividend of ₹1, resulting in a dividend yield of 0.07%
Dividend Per Share₹1
Dividend Yield0.07%
Payout Ratio12.82%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.11
52-Week Price Change17.10%
50-Day Moving Average1.23K
200-Day Moving Average1.24K
Relative Strength Index (RSI)36.88
Average Volume (3m)12.52K
Important Dates
Tatva Chintan Pharma Chem Limited upcoming earnings date is Jul 29, 2026, Before Open (Confirmed).
Last Earnings DateMay 16, 2026
Next Earnings DateJul 29, 2026
Ex-Dividend Date―
Financial Position
Tatva Chintan Pharma Chem Limited as a current ratio of 1.64, with Debt / Equity ratio of 15.40%
Current Ratio1.64
Quick Ratio0.72
Debt to Market Cap0.05
Net Debt to EBITDA1.20
Interest Coverage Ratio19.75
Taxes
In the past 12 months, Tatva Chintan Pharma Chem Limited has paid 149.55M in taxes.
Income Tax149.55M
Effective Tax Rate0.26
Enterprise Valuation
Tatva Chintan Pharma Chem Limited EV to EBITDA ratio is 27.62, with an EV/FCF ratio of -30.58.
EV to Sales5.09
EV to EBITDA27.62
EV to Free Cash Flow-30.58
EV to Operating Cash Flow86.84
Balance Sheet
Tatva Chintan Pharma Chem Limited has ₹178.47M in cash and marketable securities with ₹830.13M in debt, giving a net cash position of -₹651.66M billion.
Cash & Marketable Securities₹178.47M
Total Debt₹830.13M
Net Cash-₹651.66M
Net Cash Per Share-₹27.86
Tangible Book Value Per Share₹331.32
Margins
Gross margin is 45.19%, with operating margin of 11.13%, and net profit margin of 8.31%.
Gross Margin45.19%
Operating Margin11.13%
Pretax Margin11.27%
Net Profit Margin8.31%
EBITDA Margin18.42%
EBIT Margin11.13%
Analyst Forecast
The average price target for Tatva Chintan Pharma Chem Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast32.18%
EPS Growth Forecast636.02%